These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 713415

  • 1. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 2. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Aust N Z J Med; 1976 Aug 01; 6(3 Suppl):48-52. PubMed ID: 1071403
    [Abstract] [Full Text] [Related]

  • 3. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM, Wilson JP, Slaton PE, Foster JH, Liddle GW, Hollifield JW.
    Ann Intern Med; 1977 Jul 01; 87(1):36-42. PubMed ID: 879617
    [Abstract] [Full Text] [Related]

  • 4. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):398-401. PubMed ID: 1253700
    [Abstract] [Full Text] [Related]

  • 5. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M, Bichara M, Grüfeld JP, Barbanel C, Meyer P, Funck-Brentano JL.
    Nouv Presse Med; 1978 Feb 18; 7(7):539-43. PubMed ID: 643579
    [Abstract] [Full Text] [Related]

  • 6. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R, Lijnen P, Amery A, Reybrouck T.
    Contrib Nephrol; 1978 Feb 18; 11():175-8. PubMed ID: 699588
    [Abstract] [Full Text] [Related]

  • 7. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I, Rosenthal J.
    Dtsch Med Wochenschr; 1978 Nov 10; 103(45):1790-6. PubMed ID: 710289
    [No Abstract] [Full Text] [Related]

  • 8. [Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].
    Röckel A, Wernze H, Sabel B, Heidland A.
    Klin Wochenschr; 1977 Jul 01; 55(13):651-6. PubMed ID: 895003
    [Abstract] [Full Text] [Related]

  • 9. Saralasin infusion in renovascular and essential hypertension.
    Thien T, Hoefnagels WH.
    Neth J Med; 1980 Jul 01; 23(2):68-73. PubMed ID: 6990282
    [No Abstract] [Full Text] [Related]

  • 10. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Jul 01; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 11. False-negative saralasin responses in renovascular hypertension.
    Stokes GS, MacCarthy EP, Frost GW, Sheil AG.
    Br J Urol; 1979 Apr 01; 51(2):92-9. PubMed ID: 465980
    [Abstract] [Full Text] [Related]

  • 12. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J, Liebau G, Steiner B, Schick K, Hayduk K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Apr 01; 43():212-3. PubMed ID: 613577
    [No Abstract] [Full Text] [Related]

  • 13. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E, Brown JJ, Brown WC, Fraser R, Trust PM, Lever AF, Morton JJ, Robertson JI.
    Clin Endocrinol (Oxf); 1979 Mar 01; 10(3):227-34. PubMed ID: 455738
    [Abstract] [Full Text] [Related]

  • 14. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Lancet; 1975 Oct 25; 2(7939):784-7. PubMed ID: 78152
    [Abstract] [Full Text] [Related]

  • 15. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB, Atlas SA, Laragh JH.
    Clin Sci (Lond); 1979 Dec 25; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [Abstract] [Full Text] [Related]

  • 16. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET, Anderson GH, Goldman SH, Streeten DH.
    Kidney Int; 1976 Jun 25; 9(6):511-9. PubMed ID: 940284
    [Abstract] [Full Text] [Related]

  • 17. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G.
    Boll Soc Ital Biol Sper; 1980 Jul 15; 56(13):1367-73. PubMed ID: 7004464
    [Abstract] [Full Text] [Related]

  • 18. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G, Helber A, Meurer KA, Hummerich W, Wambach G, Kaufmann W.
    Dtsch Med Wochenschr; 1979 Mar 23; 104(12):432-7. PubMed ID: 436589
    [Abstract] [Full Text] [Related]

  • 19. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L, Ehrlich RM, Marks LS, Maxwell MH, Kaufman JJ.
    Urology; 1980 Nov 23; 16(5):453-6. PubMed ID: 7003900
    [Abstract] [Full Text] [Related]

  • 20. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A, Shaldon S, Barjon P, Mion C.
    Clin Nephrol; 1978 Feb 23; 9(2):63-7. PubMed ID: 639368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.